Neuphoria Therapeutics (NEUP) Prepaid Assets (2023 - 2026)
Neuphoria Therapeutics (NEUP) posted quarterly Prepaid Assets of $611913.0 for Q1 2026, up 2828.23% year-over-year from $20897.0 in Q1 2025, and up 2170.21% quarter-over-quarter from $26954.0 in Q4 2025.
Neuphoria Therapeutics (NEUP) Prepaid Assets (2023 - 2026) Analysis & Trends
Neuphoria Therapeutics (NEUP) has reported Prepaid Assets for 4 consecutive years, with $611913.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 2828.23% year-over-year to $611913.0; the TTM figure through Mar 2026 stood at $611913.0 (up 2828.23% YoY), while the FY2025 annual figure was $740193.0, up 61.34% from the prior year.
- Prepaid Assets improved to $611913.0 in Q1 2026 per NEUP's latest filing, from $26954.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $797478.0 in Q2 2023 and bottomed at $18469.0 in Q4 2024.
- Historically, Prepaid Assets has averaged $347566.2 across 4 years, with a median of $231108.0 in 2024.
- Annual changes were most pronounced in 2024 — Prepaid Assets plunged 42.47% — and 2026, when it soared 2828.23%.
- Neuphoria Therapeutics' Prepaid Assets stood at $797478.0 in 2023, then slumped by 97.68% to $18469.0 in 2024, then surged by 45.94% to $26954.0 in 2025, then soared by 2170.21% to $611913.0 in 2026.
- Business Quant data shows NEUP's Prepaid Assets at $611913.0 in Q1 2026, $26954.0 in Q4 2025, and $222319.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Neuphoria Therapeutics | 21.37 Mn | 1.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 611,913.00 |
| Dec 31, 2025 | 26,954.00 |
| Sep 30, 2025 | 222,319.00 |
| Jun 30, 2025 | 740,193.00 |
| Mar 31, 2025 | 20,897.00 |
| Dec 31, 2024 | 18,469.00 |
| Sep 30, 2024 | 231,108.00 |
| Jun 30, 2024 | 458,765.00 |
| Jun 30, 2023 | 797,478.00 |